These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 20436301)
21. RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38. Weilbacher A; Gutekunst M; Oren M; Aulitzky WE; van der Kuip H Cell Death Dis; 2014 Jul; 5(7):e1318. PubMed ID: 25010984 [TBL] [Abstract][Full Text] [Related]
22. Mdm2-P53 Interaction Inhibitor with Cisplatin Enhances Apoptosis in Colon and Prostate Cancer Cells In-Vitro. Gupta A; Behl T; Heer HR; Deshmukh R; Sharma PL Asian Pac J Cancer Prev; 2019 Nov; 20(11):3341-3351. PubMed ID: 31759358 [TBL] [Abstract][Full Text] [Related]
23. The p53-reactivating small molecule RITA induces senescence in head and neck cancer cells. Chuang HC; Yang LP; Fitzgerald AL; Osman A; Woo SH; Myers JN; Skinner HD PLoS One; 2014; 9(8):e104821. PubMed ID: 25119136 [TBL] [Abstract][Full Text] [Related]
24. Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation. Xia M; Knezevic D; Tovar C; Huang B; Heimbrook DC; Vassilev LT Cell Cycle; 2008 Jun; 7(11):1604-12. PubMed ID: 18520179 [TBL] [Abstract][Full Text] [Related]
25. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines. Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084 [TBL] [Abstract][Full Text] [Related]
26. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems. Shin D; Kim EH; Lee J; Roh JL Redox Biol; 2017 Oct; 13():219-227. PubMed ID: 28582730 [TBL] [Abstract][Full Text] [Related]
27. RITA enhances irradiation-induced apoptosis in p53-defective cervical cancer cells via upregulation of IRE1α/XBP1 signaling. Zhu H; Abulimiti M; Liu H; Su XJ; Liu CH; Pei HP Oncol Rep; 2015 Sep; 34(3):1279-88. PubMed ID: 26134873 [TBL] [Abstract][Full Text] [Related]
28. Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosis. Grinkevich VV; Nikulenkov F; Shi Y; Enge M; Bao W; Maljukova A; Gluch A; Kel A; Sangfelt O; Selivanova G Cancer Cell; 2009 May; 15(5):441-53. PubMed ID: 19411072 [TBL] [Abstract][Full Text] [Related]
29. Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma. de Lange J; Ly LV; Lodder K; Verlaan-de Vries M; Teunisse AF; Jager MJ; Jochemsen AG Oncogene; 2012 Mar; 31(9):1105-16. PubMed ID: 21765463 [TBL] [Abstract][Full Text] [Related]
30. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition. Aggarwal M; Saxena R; Asif N; Sinclair E; Tan J; Cruz I; Berry D; Kallakury B; Pham Q; Wang TTY; Chung FL J Exp Clin Cancer Res; 2019 Jul; 38(1):307. PubMed ID: 31307507 [TBL] [Abstract][Full Text] [Related]
31. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells. Miyachi M; Kakazu N; Yagyu S; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tsuchiya K; Iehara T; Hosoi H Clin Cancer Res; 2009 Jun; 15(12):4077-84. PubMed ID: 19509161 [TBL] [Abstract][Full Text] [Related]
32. Reactivation of mutant p53 by capsaicin, the major constituent of peppers. Garufi A; Pistritto G; Cirone M; D'Orazi G J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722 [TBL] [Abstract][Full Text] [Related]
33. Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs. Bykov VJ; Issaeva N; Zache N; Shilov A; Hultcrantz M; Bergman J; Selivanova G; Wiman KG J Biol Chem; 2005 Aug; 280(34):30384-91. PubMed ID: 15998635 [TBL] [Abstract][Full Text] [Related]
34. MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models. Tovar C; Graves B; Packman K; Filipovic Z; Higgins B; Xia M; Tardell C; Garrido R; Lee E; Kolinsky K; To KH; Linn M; Podlaski F; Wovkulich P; Vu B; Vassilev LT Cancer Res; 2013 Apr; 73(8):2587-97. PubMed ID: 23400593 [TBL] [Abstract][Full Text] [Related]
35. Novel cancer therapy by reactivation of the p53 apoptosis pathway. Bykov VJ; Wiman KG Ann Med; 2003; 35(7):458-65. PubMed ID: 14649328 [TBL] [Abstract][Full Text] [Related]
36. Rescue of p53 function by small-molecule RITA in cervical carcinoma by blocking E6-mediated degradation. Zhao CY; Szekely L; Bao W; Selivanova G Cancer Res; 2010 Apr; 70(8):3372-81. PubMed ID: 20395210 [TBL] [Abstract][Full Text] [Related]
37. RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism. Azatyan A; Gallo-Oller G; Diao Y; Selivanova G; Johnsen JI; Zaphiropoulos PG Cancer Lett; 2019 Feb; 442():341-350. PubMed ID: 30447254 [TBL] [Abstract][Full Text] [Related]
39. p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA. Hedström E; Eriksson S; Zawacka-Pankau J; Arnér ES; Selivanova G Cell Cycle; 2009 Nov; 8(21):3584-91. PubMed ID: 19838062 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer. Zhang Y; Shi Y; Li X; Du W; Luo G; Gou Y; Wang X; Guo X; Liu J; Ding J; Wu K; Fan D J Gene Med; 2010 Feb; 12(2):147-56. PubMed ID: 20020415 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]